베타 바이오닉스(BBNX)는 NASDAQ에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $21.80 (+1.73%), 시가총액 $0.42B, 52주 최저~최고 $8.86 ~ $31.99.
Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is also developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing; Bihormonal iLet, which combines automated delivery of insulin and glucagon; and iLet to treat people with insulin-dependent type-2 diabetes. It has collaboration and license a
베타 바이오닉스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
베타 바이오닉스의 현재 주가는 $21.80 (+1.73%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
베타 바이오닉스의 시가총액은 약 $0.42B입니다.
Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring peo